(Q43700112)

English

Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Sinzinger H

1

1 reference

Europe PubMed Central

26 November 2017

Lupattelli G

2

1 reference

Europe PubMed Central

26 November 2017

Chehne F

3

1 reference

Europe PubMed Central

26 November 2017

Oguogho A

4

1 reference

Europe PubMed Central

26 November 2017

Furberg CD

5

1 reference

Europe PubMed Central

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

26 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

26 November 2017

26

1 reference

Europe PubMed Central

26 November 2017

4

1 reference

Europe PubMed Central

26 November 2017

303-310

1 reference

Europe PubMed Central

26 November 2017

Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

The isoprostanes. Current knowledge and directions for future research

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00360.X

21 January 2018

Identifiers

10.1046/J.1365-2710.2001.00360.X

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43700112&oldid=2102671790"